Achaogen Receives 65,000,000 Series C Funding
Apr 08, 2010 • Deals • Efren Toscano
Transaction Detail Record
| Company Name | Achaogen |
| Information Release Date | 4/7/2010 |
| Transaction Type | Venture Equity |
| Amount | $65,000,000 |
| Round | Series C |
| Proceeds Purposes | Our mission is to discover and develop life-saving antibiotics. This financing together with non-dilutive capital that we have secured through partnerships with various government agencies will enable us to advance multiple clinical programs, including conducting a Phase 2 study in complicated urinary tract infections of ACHN-490, our lead candidate for multi-drug resistant bacterial infections. |
| Source |  |
| Transaction Investors | Frazier Healthcare Ventures Alta Partners 5AM Ventures ARCH Venture Partners Domain Associates Venrock Versant Ventures Undisclosed |
